Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MMP2 | P08253 | 5/20 | 0.42 |
| ▸ | MMP9 | P14780 | 5/20 | 0.42 |
| ▸ | MMP3 | P08254 | 2/20 | 0.42 |
| ▸ | MMP8 | P22894 | 2/20 | 0.42 |
| ▸ | MMP13 | P45452 | 2/20 | 0.42 |
| ▸ | MMP1 | P03956 | 1/20 | 0.38 |
| ▸ | ADAM17 | P78536 | 1/20 | 0.38 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.36 |
| ▸ | GFER | P55789 | 1/20 | 0.36 |
| ▸ | MAPT | P10636 | 1/20 | 0.36 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.36 |
| ▸ | PGR | P06401 | 1/20 | 0.35 |
| ▸ | HPGD | P15428 | 2/20 | 0.35 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.35 |
| ▸ | MEN1 | O00255 | 1/20 | 0.34 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.34 |
| ▸ | HTT | P42858 | 2/20 | 0.34 |
| ▸ | LMNA | P02545 | 1/20 | 0.34 |
| ▸ | TSHR | P16473 | 1/20 | 0.34 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.34 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Famoxadone SCHEMBL63351 | 1.00 | MMP2 (0.42) | MMP2MMP9MMP3MMP8MMP13 | |
| Famoxadone SCHEMBL14128616 | 1.00 | MMP2 (0.42) | MMP2MMP9MMP3MMP8MMP13 | |
| Famoxadone SCHEMBL17293878 | 0.99 | MMP2 (0.41) | MMP2MMP9MMP3MMP8MMP13 | |
| Famoxadone SCHEMBL27502240 | 0.94 | MMP2 (0.38) | MMP2MMP9MMP3MMP8MMP13 | |
| Famoxadone SCHEMBL28139781 | 0.94 | MMP1 (0.40) | MMP2MMP9MMP3MMP8MMP13 | |
| SCHEMBL27339346 | 0.91 | PGR (0.39) | MMP2MMP9MMP3MMP8MMP13 | |
| SCHEMBL9370594 | 0.91 | PGR (0.39) | MMP2MMP9MMP3MMP8MMP13 | |
| SCHEMBL7761159 | 0.89 | LMNA (0.39) | MMP2MMP9MMP3MMP8MMP13 | |
| SCHEMBL21984852 | 0.89 | KDM4E (0.39) | MMP2MMP9MMP3MMP8MMP13 | |
| SCHEMBL9869697 | 0.88 | CYP1A2 (0.42) | ALDH1A1MAPTCYP1A2HPGDKMT2A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 520 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20260137082-A1 | FUNGICIDAL COMPOSITIONS COMPRISING FLUDIOXONIL | SYNGENTA CROP PROTECTION AG (CH) | 2026-05-21 | — | — | US | claimed |
| EP-4114183-B1 | FUNGICIDAL COMPOSITIONS | SYNGENTA CROP PROTECTION AG (CH) | 2026-02-25 | — | — | EP | claimed |
| EP-3060043-B1 | PESTICIDAL COMPOSITIONS AND RELATED METHODS | CORTEVA AGRISCIENCE LLC (US) | 2025-11-26 | — | — | EP | claimed |
| EP-3578542-B1 | COMPOSITIONS HAVING PESTICIDAL UTILITY AND PROCESSES RELATED THERETO | CORTEVA AGRISCIENCE LLC (US) | 2025-11-12 | — | — | EP | claimed |
| EP-4646109-A2 | NATURAL LIPID PARTICLE FORMULATIONS FOR AGRICULTURAL APPLICATIONS | Invaio Sciences, Inc. (US) | 2025-11-12 | — | — | EP | claimed |
| EP-4384016-B1 | ACTIVE COMPOUND COMBINATIONS AND FUNGICIDE COMPOSITIONS COMPRISING THOSE | BAYER AG (DE) | 2025-09-03 | — | — | EP | claimed |
| EP-3578543-B1 | COMPOSITIONS COMPRISING MOLECULES HAVING PESTICIDAL UTILITY AND PROCESSES RELATED THERETO | CORTEVA AGRISCIENCE LLC (US) | 2025-08-20 | — | — | EP | claimed |
| US-12391729-B2 | Fusion proteins, recombinant bacteria, and methods for using recombinant bacteria | SPOGEN BIOTECH INC. (US) | 2025-08-19 | — | — | US | claimed |
| EP-3578541-B1 | COMPOSITIONS COMPRISING MOLECULES HAVING PESTICIDAL UTILITY, AND PROCESSES RELATED THERETO | CORTEVA AGRISCIENCE LLC (US) | 2025-05-28 | — | — | EP | claimed |
| US-20250017207-A1 | FUNGICIDAL COMPOSITIONS | SYNGENTA CROP PROTECTION AG (CH) | 2025-01-16 | — | — | US | claimed |
| WO-2024168193-A2 | NATURAL LIPID PARTICLE FORMULATIONS FOR AGRICULTURAL APPLICATIONS | INVAIO SCIENCES, INC. (US) | 2024-08-15 | — | — | WO | claimed |
| US-20240199709-A1 | FUSION PROTEINS, RECOMBINANT BACTERIA, AND METHODS FOR USING RECOMBINANT BACTERIA | SPOGEN BIOTECH INC (US) | 2024-06-20 | — | — | US | claimed |
| US-20240141370-A1 | AGRICULTURAL COMPOSITIONS AND RELATED METHODS | FLAGSHIP PIONEERING INNOVATIONS VI LLC (US) | 2024-05-02 | — | — | US | claimed |
| US-11905315-B2 | Fusion proteins, recombinant bacteria, and methods for using recombinant bacteria | SPOGEN BIOTECH INC. (US) | 2024-02-20 | — | — | US | claimed |
| US-11827897-B2 | Agricultural compositions and related methods | FLAGSHIP PIONEERING INNOVATIONS VI, LLC (US) | 2023-11-28 | — | — | US | claimed |
| EP-3614845-B1 | FUNGICIDAL COMBINATIONS | UPL LTD (IN) | 2023-11-01 | — | — | EP | claimed |
| WO-2023072784-A1 | FUNGICIDAL COMPOSITIONS COMPRISING FLUDIOXONIL | SYNGENTA CROP PROTECTION AG (CH) | 2023-05-04 | — | — | WO | claimed |
| WO-2023072785-A1 | FUNGICIDAL COMPOSITIONS | SYNGENTA CROP PROTECTION AG (CH) | 2023-05-04 | — | — | WO | claimed |
| EP-3644743-B1 | FUNGICIDAL COMPOSITIONS | SYNGENTA PARTICIPATIONS AG (CH) | 2022-10-26 | — | — | EP | claimed |
| US-20220064661-A1 | AGRICULTURAL COMPOSITIONS AND RELATED METHODS | FLAGSHIP PIONEERING INNOVATIONS VI, LLC | 2022-03-03 | — | — | US | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20250017207-A1 | FUNGICIDAL COMPOSITIONS | CYP51A1, BROX, DPM1 | MMP2 2427/4885MMP9 1506/4885MMP3 1373/4885 |
| US-20260137082-A1 | FUNGICIDAL COMPOSITIONS COMPRISING FLUDIOXONIL | NOTUM, CTRL, BROX | MMP2 1903/4885MMP9 1334/4885MMP3 1377/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.